TIMOLOL is indicated for the reduction of elevated intraocular pressure. In clinical trials it has been shown to reduce intraocular pressure in: – Patients with ocular hypertension
– Patients with ocular open-angle glaucoma
– Aphakic patients with glaucoma.
– Some patients with secondary glaucoma
– Patients with narrow angles and a history of spontaneous or iatrogenically induced narrow-angle closure in the opposite eye in whom reduction of intraocular pressure is necessary.
TIMOLOL is also indicated as concomitant therapy in patients with pediatric glaucoma who are inadequately controlled with other antiglaucoma therapy.